share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  07/11 10:43
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 50,000 Class A shares on 07/11/2024, as per the latest SEC filing. The shares, valued at an aggregate market price of $373,500, were originally acquired on 09/01/2016 as founder's shares in compensation for services rendered. This planned sale follows a series of transactions over the past three months where a total of 250,000 shares were sold for gross proceeds of $2,055,000. The upcoming sale is in line with a trading plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc. officer and director, Gibson Christopher, is set to sell 50,000 Class A shares on 07/11/2024, as per the latest SEC filing. The shares, valued at an aggregate market price of $373,500, were originally acquired on 09/01/2016 as founder's shares in compensation for services rendered. This planned sale follows a series of transactions over the past three months where a total of 250,000 shares were sold for gross proceeds of $2,055,000. The upcoming sale is in line with a trading plan adopted on 12/27/2023.
Recursion Pharmaceuticals, Inc.高管和董事Gibson Christopher計劃於2024年07月11日出售50,000股A類股份,根據最新的美國證券交易委員會(SEC)提交的文件。這些股份的市場總價值爲373,500美元,最初是在2016年09月01日作爲創始人股份獲得的,作爲提供服務的報酬。在過去三個月中,共進行了一系列交易,賣出了總計250,000股股份,總收益達到了2,055,000美元。即將進行的交易符合於2023年12月27日採用的交易計劃。
Recursion Pharmaceuticals, Inc.高管和董事Gibson Christopher計劃於2024年07月11日出售50,000股A類股份,根據最新的美國證券交易委員會(SEC)提交的文件。這些股份的市場總價值爲373,500美元,最初是在2016年09月01日作爲創始人股份獲得的,作爲提供服務的報酬。在過去三個月中,共進行了一系列交易,賣出了總計250,000股股份,總收益達到了2,055,000美元。即將進行的交易符合於2023年12月27日採用的交易計劃。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息